🔎 Trials Near Me

Utama › Tumor Neuroendokrin › Iowa

Kajian klinikal Tumor Neuroendokrin di Iowa

8 kajian untuk Tumor Neuroendokrin sedang mencari peserta di lokasi di Iowa.

Bandar di Iowa

Teks kajian rasmi (Bahasa Inggeris)

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

  • University of Iowa Health Care, Iowa City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07087054

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

  • Research Facility, Iowa City
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07165132

Project: Every Child for Younger Patients With Cancer

  • Blank Children's Hospital, Des Moines
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City
Mengambil pesertaKajian pemerhatian
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

Integrated Cancer Repository for Cancer Research

  • Methodist Jennie Edmundson Hospital, Council Bluffs
  • Covenant Medical Center, Inc, Waterloo
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

  • University of Iowa, Iowa City
Mengambil pesertaFasa 1/2
Umur 18 hingga 90 · Semua jantina · Dikemas kini 14 Mei 2026 · NCT05636618

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

  • Research Facility, Iowa City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Mac 2026 · NCT05477576

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Iowa City
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

  • Holden Comprehensive Cancer Center at the University of Iowa, Iowa City
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2025 · NCT06395402

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.